Lab Space | Studiolabs
Description: Founded in 2003 by Rebecka Belldegrun, M.D. and Arie Belldegrun, M.D., FACS, Bellco Capital is a direct investment firm that focuses on deploying capital to create and support companies with bold ambitions of exponential transformation in life science, real estate, consumer products, media, and other sectors.
About Us Leadership Portfolio News Investing in Exponential Transformation Founded in 2003 by Rebecka Belldegrun, M.D. and Arie Belldegrun, M.D., Bellco Capital is a direct investment firm that focuses on deploying capital to create and support companies with bold ambitions of exponential transformation in life science, real estate, consumer products, media, and other sectors. At Bellco Capital, we believe that each and every investment is the start of a relationship that should benefit all involved. Our st
Leadership Arie Belldegrun, M.D. Rebecka Belldegrun, M.D. Josh Bradley Read Full Profiles Portfolio We have a longstanding track record of founding and investing in life sciences companies that shift paradigms. Our most notable impact has been leading the cell therapy field with the founding of Kite Pharma, acquired by Gilead Sciences in 2017 for $11.9 billion, and Allogene Therapeutics, the second-largest biotechnology IPO of 2018.
See Our Portfolio Kite Pharma celebrating a successful IPO with gross proceeds of $146.6 million in June 2014. Arie Belldegrun, honored with the prestigious EY Master Entrepreneur Award during the Entrepreneur of the Year 2018 Awards Gala on Thursday, June 14, 2018 in Los Angeles. Supervisor Mark Ridley Thomas extending LA County’s congratulations to Drs. Belldegrun at the groundbreaking ceremony of Kite Pharma’s El Segundo manufacturing facility on August 6, 2015. Rebecka and Arie Belldegrun ring the Nasda
Lab Space | Studiolabs